Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05920356
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-05-23
Brief Title:
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIBC Nonsquamous Non-Small Cell Lung Cancers CodeBreaK 202
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-23
First Submit QC Date:
June 26 2023
Study First Post Date:
2023-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-07-12
Last Update Post Date Type:
ACTUAL